Co-Diagnostics, Inc. Share-based Payment Arrangement, Expense
Co-Diagnostics, Inc. (CODX) reported Share-based Payment Arrangement, Expense of $2.25 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-03-31
- Co-Diagnostics, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $291.98K, a 77.85% decline year-over-year.
- Co-Diagnostics, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $500.58K, a 52.12% decline year-over-year.
- Co-Diagnostics, Inc. share-based payment arrangement, expense for the quarter ending 2025-06-30 was $580.26K, a 61.31% decline year-over-year.
- Co-Diagnostics, Inc. share-based payment arrangement, expense for the quarter ending 2025-03-31 was $875.23K, a 44.30% decline year-over-year.
- Co-Diagnostics, Inc. share-based payment arrangement, expense for fiscal 2025 was $2.25M, a 58.64% decline from fiscal 2024.
- Co-Diagnostics, Inc. share-based payment arrangement, expense for fiscal 2024 was $5.43M, a 34.81% decline from fiscal 2023.
- Co-Diagnostics, Inc. share-based payment arrangement, expense for fiscal 2023 was $8.34M, a 10.52% increase from fiscal 2022.
- Co-Diagnostics, Inc. share-based payment arrangement, expense for fiscal 2022 was $7.54M, a 36.92% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $291.98K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $792.56K derived: sum of 2 quarters · filed 2026-03-31 | $1.37M derived: sum of 3 quarters · filed 2026-03-31 | $2.25M 10-K · filed 2026-03-31 | ||
| 2025-09-30 | $500.58K 10-Q · filed 2025-11-13 | $1.08M derived: sum of 2 quarters · filed 2025-11-13 | $1.96M 10-Q · filed 2025-11-13 | $3.27M derived: sum of 4 quarters · filed 2026-03-31 | ||
| 2025-06-30 | $580.26K 10-Q · filed 2025-08-14 | $1.46M 10-Q · filed 2025-08-14 | $2.77M derived: sum of 3 quarters · filed 2026-03-31 | $3.82M derived: sum of 4 quarters · filed 2026-03-31 | ||
| 2025-03-31 | $875.23K 10-Q · filed 2025-05-08 | $2.19M derived: sum of 2 quarters · filed 2026-03-31 | $3.24M derived: sum of 3 quarters · filed 2026-03-31 | $4.74M derived: sum of 4 quarters · filed 2026-03-31 | ||
| 2024-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $2.36M derived: sum of 2 quarters · filed 2026-03-31 | $3.86M derived: sum of 3 quarters · filed 2026-03-31 | $5.43M 10-K · filed 2026-03-31 | ||
| 2024-09-30 | $1.05M 10-Q · filed 2025-11-13 | $2.55M derived: sum of 2 quarters · filed 2025-11-13 | $4.12M 10-Q · filed 2025-11-13 | $5.94M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $1.50M 10-Q · filed 2025-08-14 | $3.07M 10-Q · filed 2025-08-14 | $4.90M derived: sum of 3 quarters · filed 2025-08-14 | $7.07M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $1.57M 10-Q · filed 2025-05-08 | $3.40M derived: sum of 2 quarters · filed 2025-05-08 | $5.57M derived: sum of 3 quarters · filed 2025-05-08 | $7.74M derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $4.00M derived: sum of 2 quarters · filed 2025-03-27 | $6.17M derived: sum of 3 quarters · filed 2025-03-27 | $8.34M 10-K · filed 2025-03-27 | ||
| 2023-09-30 | $2.17M 10-Q · filed 2024-11-07 | $4.34M derived: sum of 2 quarters · filed 2024-11-07 | $6.51M 10-Q · filed 2024-11-07 | $8.92M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $2.17M 10-Q · filed 2024-08-08 | $2.17M 10-Q · filed 2023-08-10 | $4.34M 10-Q · filed 2024-08-08 | $4.34M 10-Q · filed 2023-08-10 | $6.74M derived: sum of 3 quarters · filed 2024-08-08 | $8.97M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $2.17M 10-Q · filed 2024-05-09 | $4.57M derived: sum of 2 quarters · filed 2024-05-09 | $6.80M derived: sum of 3 quarters · filed 2024-05-09 | $8.34M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $4.63M derived: sum of 2 quarters · filed 2024-03-14 | $6.17M derived: sum of 3 quarters · filed 2024-03-14 | $7.54M 10-K · filed 2024-03-14 | ||
| 2022-09-30 | $2.23M 10-Q · filed 2023-11-09 | $3.76M derived: sum of 2 quarters · filed 2023-11-09 | $5.14M 10-Q · filed 2023-11-09 | $6.80M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $1.53M 10-Q · filed 2023-08-10 | $2.91M 10-Q · filed 2023-08-10 | $4.57M derived: sum of 3 quarters · filed 2023-08-10 | $5.98M derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $1.38M 10-Q · filed 2023-05-11 | $3.03M derived: sum of 2 quarters · filed 2023-05-11 | $4.44M derived: sum of 3 quarters · filed 2023-05-11 | $5.37M derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $3.07M derived: sum of 2 quarters · filed 2023-03-16 | $4.00M derived: sum of 3 quarters · filed 2023-03-16 | $5.51M 10-K · filed 2023-03-16 | ||
| 2021-09-30 | $1.41M 10-Q · filed 2022-11-10 | $1.41M 10-Q · filed 2021-11-12 | $2.34M derived: sum of 2 quarters · filed 2022-11-10 | $3.85M 10-Q · filed 2022-11-10 | $4.42M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $927.34K 10-Q · filed 2022-08-11 | $927.34K 10-Q · filed 2021-08-12 | $2.44M 10-Q · filed 2022-08-11 | $3.01M derived: sum of 3 quarters · filed 2022-08-11 | $4.05M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $1.51M 10-Q · filed 2022-05-12 | $2.08M derived: sum of 2 quarters · filed 2022-05-12 | $3.13M derived: sum of 3 quarters · filed 2022-05-12 | $3.82M derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $570.66K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $1.61M derived: sum of 2 quarters · filed 2022-03-24 | $2.31M derived: sum of 3 quarters · filed 2022-03-24 | $2.74M 10-K · filed 2022-03-24 | ||
| 2020-09-30 | $1.04M 10-Q · filed 2021-11-12 | $1.07M 10-Q · filed 2020-11-16 | $1.73M derived: sum of 2 quarters · filed 2021-11-12 | $2.17M 10-Q · filed 2021-11-12 | $2.69M derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | $691.42K 10-Q · filed 2021-08-12 | $1.12M 10-Q · filed 2021-08-12 | $1.64M derived: sum of 3 quarters · filed 2021-08-12 | $1.92M derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $432.82K 10-Q · filed 2021-05-13 | $950.58K derived: sum of 2 quarters · filed 2021-05-13 | $1.23M derived: sum of 3 quarters · filed 2021-05-13 | $1.35M derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2019-12-31 | $517.75K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $793.69K derived: sum of 2 quarters · filed 2021-03-25 | $920.17K derived: sum of 3 quarters · filed 2021-03-25 | $1.09M 10-K · filed 2021-03-25 | ||
| 2019-09-30 | $275.93K 10-Q · filed 2020-11-16 | $402.42K derived: sum of 2 quarters · filed 2020-11-16 | $570.63K 10-Q · filed 2020-11-16 | |||
| 2019-06-30 | $126.48K 10-Q · filed 2019-08-14 | $126.48K 10-Q · filed 2019-08-14 | ||||
| 2019-03-31 | $87.79K 10-Q · filed 2019-05-14 | |||||
| 2018-06-30 | $214.28K 10-Q · filed 2019-08-14 | $214.28K 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |